Source: Eur Respir J 2005; 26: 1069-1073
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Higashi A., Higashi N., Tsuburai T., Takeuchi Y., Taniguchi M., Mita H., Saito A., Takatori K., Arimura K., Akiyama K.. Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis. Eur Respir J 2005; 26: 1069-1073

Member's Comments

No comment yet.

Related content which might interest you: Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Evidence of mast cell activation and leukotriene release after mannitol inhalation Source: Eur Respir J 2003; 22: 491-496 Year: 2003 Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009 Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006 Surfactant protein A in chronic extrinsic allergic alveolitis Source: Eur Respir J 2012; 39: 1543-1544 Year: 2012 Lipid mediators in severe asthma Source: Eur Respir Mon 2011; 51: 218-235 Year: 2011 Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Source: Eur Respir J 2008; 32: 437-442 Year: 2008 Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003 Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2014 – Airway biomarkers Year: 2014 Antigen-induced formation of prostaglandin D2 in mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005 Prostaglandin D2 (PGD2) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice Source: Eur Respir J 2010; 36: 1120-1130 Year: 2010 Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Role of leukotrienes in airway inflammation Source: Annual Congress 2004 - Early management of inflammatory airway diseases - Can we do better? Year: 2004 Higher expression of lipoxygenase and cyclooxygenase pathways in bronchial than alveolar lavage from allergic asthmatics Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Imbalance of anti-inflammatory (resolving D1) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 The early allergic response in small airways of human precision-cut lung slices Source: Eur Respir J 2003; 21: 1024-1032 Year: 2003 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011